[HTML][HTML] Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data …

L Martinez, O Cords, Q Liu… - The Lancet Global …, 2022 - thelancet.com
Background BCG vaccines are given to more than 100 million children every year, but there
is considerable debate regarding the effectiveness of BCG vaccination in preventing …

The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

L Martinez, O Cords, CR Horsburgh, JR Andrews… - The Lancet, 2020 - thelancet.com
Background Tens of millions of children are exposed to Mycobacterium tuberculosis globally
every year; however, there are no contemporary estimates of the risk of developing …

[HTML][HTML] Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults

D Menzies, M Adjobimey, R Ruslami… - … England Journal of …, 2018 - Mass Medical Soc
Background A 9-month regimen of isoniazid can prevent active tuberculosis in persons with
latent tuberculosis infection. However, the regimen has been associated with poor …

[HTML][HTML] Impact of the COVID-19 pandemic on tuberculosis control: an overview

KA Alene, K Wangdi, ACA Clements - Tropical medicine and infectious …, 2020 - mdpi.com
Throughout history, pandemics of viral infections such as HIV, Ebola and Influenza have
disrupted health care systems, including the prevention and control of endemic diseases …

[HTML][HTML] Effectiveness of contact tracing in the control of infectious diseases: a systematic review

AD Hossain, J Jarolimova, A Elnaiem… - The Lancet Public …, 2022 - thelancet.com
Background Contact tracing is used for multiple infectious diseases, most recently for COVID-
19, but data regarding its effectiveness in disease control are scarce. To address this …

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

MJA Reid, N Arinaminpathy, A Bloom, BR Bloom… - The Lancet, 2019 - thelancet.com
Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

[HTML][HTML] Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection

JD Simmons, CM Stein, C Seshadri, M Campo… - Nature Reviews …, 2018 - nature.com
Mycobacterium tuberculosis is a leading cause of mortality worldwide and establishes a
long-lived latent infection in a substantial proportion of the human population. Multiple lines …

[HTML][HTML] IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure

LL Lu, MT Smith, KKQ Yu, C Luedemann… - Nature medicine, 2019 - nature.com
Abstract Exposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical
outcomes including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb …

Risk factors for tuberculosis

P Narasimhan, J Wood, CR MacIntyre… - Pulmonary …, 2013 - Wiley Online Library
The risk of progression from exposure to the tuberculosis bacilli to the development of active
disease is a two‐stage process governed by both exogenous and endogenous risk factors …

Contact investigation for tuberculosis: a systematic review and meta-analysis

GJ Fox, SE Barry, WJ Britton… - European Respiratory …, 2013 - Eur Respiratory Soc
Investigation of contacts of patients with tuberculosis (TB) is a priority for TB control in high-
income countries, and is increasingly being considered in resource-limited settings. This …